GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 8/14/2026 5:07:41 PM | Small | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Assets $368,735,835 | EPS -$0.70 | ||
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 8/13/2026 4:12:09 PM | View | Financials | Earnings | SEC | 2Q 2026 | Assets $368,735,835 | EPS -$0.70 | Export Earnings Model | ||
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 5/13/2026 5:32:51 PM | Small | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Assets $326,283,517 | EPS -$0.59 | ||
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 5/12/2026 4:07:07 PM | View | Financials | Earnings | SEC | 1Q 2026 | Assets $326,283,517 | EPS -$0.59 | Export Earnings Model | ||
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 4/10/2026 4:36:45 PM | View | Proxy | SEC | Y 2025 | ||||||
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 3/17/2026 5:11:42 PM | Small | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Assets $355,949,294 | EPS -$2.26 | ||
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 3/12/2026 4:01:54 PM | View | Financials | Earnings | SEC | Y 2025 | Assets $355,949,294 | EPS -$0.62 | Export Earnings Model | ||
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 11/10/2025 5:35:41 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Assets $126,438,207 | EPS -$0.54 | ||
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 11/10/2025 4:03:11 PM | View | Financials | Earnings | SEC | 3Q 2025 | Assets $126,438,207 | EPS -$0.54 | Export Earnings Model | ||
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 8/11/2025 5:35:55 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Assets $133,569,011 | EPS -$0.57 | ||
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 8/11/2025 4:07:12 PM | View | Financials | Earnings | SEC | 2Q 2025 | Assets $133,569,011 | EPS -$0.57 | Export Earnings Model | ||
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 5/14/2025 4:43:53 PM | Small | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Assets $153,765,973 | EPS -$0.53 | ||
| Capricor Therapeutics, Inc. (CAPR) | 5/13/2025 4:08:55 PM | View | Financials | Earnings | WIRE | 1Q 2025 | Assets $153,765,973 | EPS -$0.53 | Export Earnings Model | ||
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 5/13/2025 4:08:35 PM | View | Financials | Earnings | SEC | 1Q 2025 | Assets $153,765,973 | EPS -$0.53 | Export Earnings Model | ||
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 4/8/2025 5:16:14 PM | View | Proxy | SEC | Y 2024 | ||||||
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 3/26/2025 4:25:52 PM | Small | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $22,270,465 -11.5% | Assets $170,481,086 | EPS -$1.15 | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 3/19/2025 4:15:49 PM | View | Financials | Earnings | SEC | Y 2024 | Rev $11,130,509 -7.9% | Assets $170,481,086 | EPS -$0.11 | Export Earnings Model | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 11/14/2024 4:41:08 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Rev: $2,261,642 -63.4% | Assets $92,951,613 | EPS -$0.38 | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 11/13/2024 4:04:48 PM | View | Financials | Earnings | SEC | 3Q 2024 | Rev $2,261,642 -63.4% | Assets $92,951,613 | EPS -$0.38 | Export Earnings Model | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 10/16/2024 4:26:43 PM | View | Financials | Earnings (Prelim) | SEC | 3Q 2024 | Export Earnings Model | ||||
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 8/8/2024 5:18:56 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Rev: $3,971,438 +1.4% | Assets $38,277,453 | EPS -$0.35 | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 8/7/2024 4:13:07 PM | View | Financials | Earnings | SEC | 2Q 2024 | Rev $3,971,438 +1.4% | Assets $38,277,453 | EPS -$0.35 | Export Earnings Model | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 5/14/2024 9:16:19 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $4,906,877 +64.3% | Assets $49,444,442 | EPS -$0.31 | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 5/13/2024 4:07:13 PM | View | Financials | Earnings | SEC | 1Q 2024 | Rev $4,906,877 +64.3% | Assets $49,444,442 | EPS -$0.31 | Export Earnings Model | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 4/1/2024 6:01:37 AM | View | Proxy | SEC | Y 2023 | ||||||
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 3/11/2024 8:45:38 AM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Rev: $25,178,066 +886.8% | Assets $58,734,327 | EPS -$0.83 | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 2/29/2024 4:08:16 PM | View | Financials | Earnings | SEC | Y 2023 | Rev $12,088,089 +1,159.3% | Assets $58,734,327 | EPS $0.02 | Export Earnings Model | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 11/14/2023 8:57:48 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Rev: $6,185,814 +288.7% | Assets $37,152,330 | EPS -$0.25 | |
| Capricor Therapeutics, Inc. (CAPR) | 11/14/2023 4:06:47 PM | View | Financials | Earnings | WIRE | 3Q 2023 | Rev $6,185,814 +288.7% | Assets $37,152,330 | EPS -$0.25 | Export Earnings Model | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 8/8/2023 8:17:58 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Rev: $3,917,467 | Assets $46,011,198 | EPS -$0.29 | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 8/7/2023 4:08:01 PM | View | Financials | Earnings | SEC | 2Q 2023 | Rev $3,917,467 | Assets $46,011,198 | EPS -$0.29 | Export Earnings Model | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 5/12/2023 9:11:27 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Rev: $2,986,696 | Assets $53,863,409 | EPS -$0.31 | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 5/11/2023 4:05:11 PM | View | Financials | Earnings | SEC | 1Q 2023 | Rev $2,986,696 | Assets $53,863,409 | EPS -$0.31 | Export Earnings Model | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 4/17/2023 5:09:04 PM | View | Proxy | SEC | Y 2022 | ||||||
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 3/17/2023 5:10:43 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Rev: $2,551,469 +941.8% | Assets $50,094,910 | EPS -$1.18 | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 3/15/2023 4:02:43 PM | View | Financials | Earnings | SEC | Y 2022 | Rev $959,903 | Assets $50,094,910 | EPS -$0.31 | Export Earnings Model | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 11/10/2022 5:24:47 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Rev: $1,591,566 | Assets $53,928,107 | EPS -$0.26 | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 11/10/2022 4:04:20 PM | View | Financials | Earnings | SEC | 3Q 2022 | Rev $1,591,566 | Assets $53,928,107 | EPS -$0.26 | Export Earnings Model | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 8/12/2022 6:18:22 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Assets $58,065,574 | EPS -$0.29 | ||
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 8/10/2022 4:03:50 PM | View | Financials | Earnings | SEC | 2Q 2022 | Assets $58,065,574 | EPS -$0.29 | Export Earnings Model | ||
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 5/11/2022 5:19:04 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Assets $64,921,918 | EPS -$0.32 | ||
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 5/10/2022 4:04:11 PM | View | Financials | Earnings | SEC | 1Q 2022 | Assets $64,921,918 | EPS -$0.32 | Export Earnings Model | ||
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 4/12/2022 5:02:07 PM | View | Proxy | SEC | Y 2021 | ||||||
| Capricor Therapeutics, Inc. (CAPR) | 3/28/2022 8:31:29 AM | View | Financials | Earnings | WIRE | Y 2021 | Rev $0 | Assets $41,330,323 | EPS -$0.26 | Export Earnings Model | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 3/11/2022 6:12:03 AM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Rev: $244,898 -21.1% | Assets $41,330,323 | EPS -$0.87 | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 3/10/2022 4:04:45 PM | View | Financials | Earnings | SEC | Y 2021 | Rev $0 | Assets $41,330,323 | EPS -$0.26 | Export Earnings Model | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 11/12/2021 6:14:17 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Assets $43,100,521 | EPS -$0.17 | ||
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 11/9/2021 4:03:43 PM | View | Financials | Earnings | SEC | 3Q 2021 | Assets $43,100,521 | EPS -$0.17 | Export Earnings Model | ||
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 8/13/2021 9:23:31 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Rev: $204,082 +309.3% | Assets $39,930,052 | EPS -$0.21 | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 8/12/2021 4:04:16 PM | View | Financials | Earnings | SEC | 2Q 2021 | Rev $204,082 +309.3% | Assets $39,930,052 | EPS -$0.21 | Export Earnings Model | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 5/14/2021 5:24:49 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Rev: $40,816 -78.0% | Assets $43,544,401 | EPS -$0.23 | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 5/13/2021 4:07:47 PM | View | Financials | Earnings | SEC | 1Q 2021 | Rev $40,816 -78.0% | Assets $43,544,401 | EPS -$0.23 | Export Earnings Model | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 4/20/2021 4:32:03 PM | View | Proxy | SEC | Y 2020 | ||||||
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 3/15/2021 5:31:48 PM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Rev: $310,250 -69.1% | Assets $34,618,796 | EPS -$0.88 | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 3/11/2021 4:03:06 PM | View | Financials | Earnings | SEC | Y 2020 | Rev $57,830 -74.0% | Assets $34,618,796 | EPS -$0.37 | Export Earnings Model | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 11/13/2020 5:21:51 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Rev: $16,863 -88.1% | Assets $36,187,057 | EPS -$0.23 | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 11/12/2020 4:02:54 PM | View | Financials | Earnings | SEC | 3Q 2020 | Rev $16,863 -88.1% | Assets $36,187,057 | EPS -$0.23 | Export Earnings Model | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 8/10/2020 8:15:10 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Rev: $49,864 -87.8% | Assets $37,125,954 | EPS -$0.23 | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 8/6/2020 4:03:57 PM | View | Earnings | SEC | 2Q 2020 | Rev $49,864 -87.8% | Assets $37,125,954 | EPS -$0.23 | |||
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 5/15/2020 5:06:15 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Rev: $185,693 -19.4% | Assets $14,293,789 | EPS -$0.30 | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 5/14/2020 4:01:15 PM | View | Financials | Earnings | SEC | 1Q 2020 | Rev $185,693 -19.4% | Assets $14,293,789 | EPS -$0.30 | Export Earnings Model | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 4/17/2020 6:02:16 AM | View | Proxy | SEC | Y 2019 | ||||||
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 3/27/2020 8:46:19 AM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Rev: $1,005,028 -39.9% | Assets $11,113,637 | EPS -$2.06 | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 3/18/2020 4:02:44 PM | View | Financials | Earnings | SEC | Y 2019 | Rev $222,100 -65.7% | Assets $11,113,637 | EPS -$0.30 | Export Earnings Model | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 11/8/2019 5:19:42 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Rev: $142,071 -35.2% | Assets $7,907,415 | EPS -$0.43 | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 11/7/2019 4:02:58 PM | View | Financials | Earnings | SEC | 3Q 2019 | Rev $142,071 -35.2% | Assets $7,907,415 | EPS -$0.43 | Export Earnings Model | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 8/8/2019 8:18:24 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Rev: $410,353 +1.6% | Assets $7,306,844 | EPS -$0.59 | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 8/6/2019 4:01:57 PM | View | Financials | Earnings | SEC | 2Q 2019 | Rev $410,353 +1.6% | Assets $7,306,844 | EPS -$0.59 | Export Earnings Model | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 5/14/2019 5:16:04 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Rev: $230,504 -42.4% | Assets $8,617,505 | EPS -$0.75 | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 5/13/2019 4:01:52 PM | View | Financials | Earnings | SEC | 1Q 2019 | Rev $230,504 -42.4% | Assets $8,617,505 | EPS -$0.75 | Export Earnings Model | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 4/30/2019 6:26:14 AM | View | Proxy | SEC | Y 2018 | ||||||
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 3/29/2019 7:13:20 AM | Micro | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Rev: $1,671,356 -37.3% | Assets $9,247,065 | EPS -$0.52 | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 3/28/2019 4:01:53 PM | View | Financials | Earnings | SEC | Y 2018 | Rev $648,082 +36.2% | Assets $9,247,065 | EPS -$0.11 | Export Earnings Model | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 11/14/2018 4:52:12 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Rev: $219,249 -30.0% | Assets $12,232,816 | EPS -$1.35 | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 11/13/2018 4:01:52 PM | View | Financials | Earnings | SEC | 3Q 2018 | Rev $219,249 -30.0% | Assets $12,232,816 | EPS -$1.35 | Export Earnings Model | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 8/13/2018 6:07:04 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Rev: $403,960 -59.5% | Assets $14,327,071 | EPS -$1.42 | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 8/9/2018 4:02:42 PM | View | Financials | Earnings | SEC | 2Q 2018 | Rev $403,960 -59.5% | Assets $14,327,071 | EPS -$1.42 | Export Earnings Model | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 5/14/2018 6:22:27 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Rev: $400,066 -54.6% | Assets $15,388,422 | EPS -$0.14 | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 5/10/2018 4:01:57 PM | View | Financials | Earnings | SEC | 1Q 2018 | Rev $400,066 -54.6% | Assets $15,388,422 | EPS -$0.14 | Export Earnings Model | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 4/26/2018 6:09:19 AM | View | Proxy | SEC | Y 2017 | ||||||
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 3/22/2018 5:35:43 PM | Micro | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Rev: $2,666,340 -33.3% | Assets $16,273,789 | EPS $0.09 | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 3/14/2018 4:01:27 PM | View | Financials | Earnings | SEC | Y 2017 | Rev $475,799 -47.5% | Assets $16,273,789 | EPS $0.53 | Export Earnings Model | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 11/14/2017 6:15:01 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Rev: $313,271 -58.1% | Assets $15,793,539 | EPS -$0.12 | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 11/8/2017 4:03:05 PM | View | Financials | Earnings | SEC | 3Q 2017 | Rev $313,271 -58.1% | Assets $15,793,539 | EPS -$0.12 | Export Earnings Model | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 8/14/2017 4:35:02 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Rev: $996,462 -11.8% | Assets $14,218,267 | EPS -$0.16 | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 8/10/2017 4:05:40 PM | View | Financials | Earnings | SEC | 2Q 2017 | Rev $996,462 -11.8% | Assets $14,218,267 | EPS -$0.16 | Export Earnings Model | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 5/15/2017 5:23:16 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Rev: $880,808 -27.5% | Assets $14,068,041 | EPS -$0.17 | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 5/15/2017 4:19:45 PM | View | Financials | Earnings | SEC | 1Q 2017 | Rev $880,808 -27.5% | Assets $14,068,041 | EPS -$0.17 | Export Earnings Model | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 4/21/2017 6:10:58 AM | View | Proxy | SEC | Y 2016 | ||||||
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 3/16/2017 5:30:00 AM | Micro | View | Financials | 10-K | SEC | Y 2016 ending: 12/31/2016 | Rev: $3,998,618 -27.5% | Assets $18,747,355 | EPS -$1.01 | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 3/15/2017 4:15:25 PM | View | Financials | Earnings | SEC | Y 2016 | Rev $906,930 -19.3% | Assets $18,747,355 | EPS -$0.20 | Export Earnings Model | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 11/14/2016 4:04:28 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2016 ending: 9/30/2016 | Rev: $746,781 -43.2% | Assets $24,471,820 | EPS -$0.29 | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 11/10/2016 4:05:23 PM | View | Financials | Earnings | SEC | 3Q 2016 | Rev $746,781 -43.2% | Assets $24,471,820 | EPS -$0.29 | Export Earnings Model | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 8/15/2016 5:15:17 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2016 ending: 6/30/2016 | Rev: $1,129,819 -12.5% | Assets $13,892,196 | EPS -$0.26 | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 8/15/2016 4:07:04 PM | View | Financials | Earnings | SEC | 2Q 2016 | Rev $1,129,819 -12.5% | Assets $13,892,196 | EPS -$0.26 | Export Earnings Model | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 5/13/2016 5:19:46 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2016 ending: 3/31/2016 | Rev: $1,215,089 -32.0% | Assets $16,984,850 | EPS -$0.26 | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 5/12/2016 4:05:25 PM | View | Financials | Earnings | SEC | 1Q 2016 | Rev $1,215,089 -32.0% | Assets $16,984,850 | EPS -$0.26 | Export Earnings Model | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 4/28/2016 8:00:49 AM | View | Proxy | SEC | Y 2015 | ||||||
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 3/30/2016 5:37:08 PM | Micro | View | Financials | 10-K | SEC | Y 2015 ending: 12/31/2015 | Rev: $5,517,648 +15.3% | Assets $16,069,572 | EPS -$0.81 | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 3/17/2016 4:01:39 PM | View | Financials | Earnings | SEC | Y 2015 | Rev $1,123,396 -19.9% | Assets $16,069,572 | EPS -$0.21 | Export Earnings Model | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 11/13/2015 4:28:54 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2015 ending: 9/30/2015 | Rev: $1,314,884 +1.0% | Assets $19,882,289 | EPS -$0.18 | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 11/12/2015 5:28:56 PM | View | Financials | Earnings | SEC | 3Q 2015 | Rev $1,314,884 +1.0% | Assets $19,882,289 | EPS -$0.18 | Export Earnings Model | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 8/14/2015 8:32:18 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2015 ending: 6/30/2015 | Rev: $1,291,466 +24.0% | Assets $23,690,830 | EPS -$0.19 | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 8/13/2015 4:07:35 PM | View | Financials | Earnings | SEC | 2Q 2015 | Rev $1,291,466 +24.0% | Assets $23,690,830 | EPS -$0.19 | Export Earnings Model | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 5/15/2015 6:55:17 PM | View | Proxy | SEC | Y 2014 | ||||||
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 5/13/2015 8:01:15 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2015 ending: 3/31/2015 | Rev: $1,787,902 +71.6% | Assets $27,471,047 | EPS -$0.23 | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 5/12/2015 4:00:31 PM | View | Financials | Earnings | SEC | 1Q 2015 | Rev $1,787,902 +71.6% | Assets $27,471,047 | EPS -$0.23 | Export Earnings Model | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 3/16/2015 5:28:14 PM | Micro | View | Financials | 10-K | SEC | Y 2014 ending: 12/31/2014 | Rev: $4,786,700 +851.2% | Assets $13,632,072 | EPS -$0.53 | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 11/14/2014 5:30:00 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2014 ending: 9/30/2014 | Rev: $1,301,467 +1,518.1% | Assets $16,282,719 | EPS -$0.13 | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 11/12/2014 8:38:25 AM | View | Financials | Earnings | SEC | 3Q 2014 | Rev $1,301,467 +1,518.1% | Assets $16,282,719 | EPS -$0.13 | Export Earnings Model | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 9/17/2014 1:35:13 PM | View | Proxy | SEC | Y 2013 | ||||||
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 8/14/2014 4:40:45 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2014 ending: 6/30/2014 | Rev: $1,041,667 +449.7% | Assets $18,437,454 | EPS -$0.13 | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 8/13/2014 2:16:08 PM | View | Financials | Earnings | SEC | 2Q 2014 | Rev $1,041,667 +449.7% | Assets $18,437,454 | EPS -$0.13 | Export Earnings Model | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 5/15/2014 5:16:03 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2014 ending: 3/31/2014 | Rev: $1,041,667 +346.5% | Assets $15,976,704 | EPS -$0.10 | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | 3/31/2014 5:28:30 PM | Micro | View | Financials | 10-K | SEC | Y 2013 ending: 12/31/2013 | Rev: $503,233 +157.4% | Assets $5,537,907 | EPS -$0.85 | |
| Nile Therapeutics, Inc. (CAPR) | 11/14/2013 6:52:38 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2013 ending: 9/30/2013 | Rev: $80,432 | Assets $114,366 | EPS -$0.15 | |
| Nile Therapeutics, Inc. (CAPR) | 10/10/2013 11:03:07 AM | View | Proxy | SEC | Y 2012 | ||||||
| Nile Therapeutics, Inc. (CAPR) | 8/14/2013 6:29:06 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2013 ending: 6/30/2013 | Rev: $189,510 | Assets $294,822 | EPS -$0.16 | |
| Nile Therapeutics, Inc. (CAPR) | 6/21/2013 3:34:57 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2013 ending: 3/31/2013 | Rev: $233,291 +19.3% | Assets $415,308 | EPS -$0.14 | |
| Nile Therapeutics, Inc. (CAPR) | 6/21/2013 3:32:41 PM | Micro | View | Financials | 10-K | SEC | Y 2012 ending: 12/31/2012 | Rev: $195,500 -85.6% | Assets $5,423,590 | EPS -$0.21 | |
| Nile Therapeutics, Inc. (CAPR) | 6/21/2013 3:29:18 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2012 ending: 9/30/2012 | Assets $495,225 | EPS -$0.01 | ||
| Nile Therapeutics, Inc. (CAPR) | 9/10/2012 3:54:15 PM | Micro | View | Financials | 10-Q/A | SEC | 2Q 2012 ending: 6/30/2012 | Assets $1,000,172 | EPS -$0.01 | ||
| Nile Therapeutics, Inc. (CAPR) | 5/15/2012 5:28:39 PM | Micro | View | Financials | 10-Q/A | SEC | 1Q 2012 ending: 3/31/2012 | Rev: $195,500 | Assets $716,006 | EPS -$0.02 | |
| Nile Therapeutics, Inc. (CAPR) | 5/15/2012 4:11:07 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2012 ending: 3/31/2012 | Rev: $195,500 | Assets $716,006 | EPS -$0.02 | |
| NILE THERAPEUTICS, INC. (CAPR) | 4/2/2012 5:30:59 PM | Micro | View | Financials | 10-K | SEC | Y 2011 ending: 12/31/2011 | Rev: $1,354,500 | Assets $1,372,170 | EPS -$0.13 | |
| NILE THERAPEUTICS, INC. (CAPR) | 11/14/2011 7:00:44 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2011 ending: 9/30/2011 | Rev: $813,000 | Assets $3,090,813 | EPS -$0.03 | |
| NILE THERAPEUTICS, INC. (CAPR) | 8/15/2011 7:01:47 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2011 ending: 6/30/2011 | Rev: $346,000 | Assets $3,704,348 | EPS -$0.03 | |
| Nile Therapeutics, Inc. (CAPR) | 4/8/2011 7:03:33 AM | View | Proxy | SEC | Y 2010 | ||||||
| Nile Therapeutics, Inc. (CAPR) | 6/15/2010 4:44:00 PM | View | Proxy | SEC | Y 2009 | ||||||
| Nile Therapeutics, Inc. (CAPR) | 11/2/2009 4:17:41 PM | View | Proxy | SEC | Y 2008 | ||||||
| Nile Therapeutics, Inc. (CAPR) | 8/18/2009 6:01:32 AM | View | Financials | Earnings | SEC | Export Earnings Model | |||||
| Nile Therapeutics, Inc. (CAPR) | 3/9/2009 12:00:00 AM | View | Financials | Earnings | SEC | Y 2008 | Export Earnings Model |